Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

What is AMGN's Pretax Income (Earnings) Margin?

  Amgen Inc ( AMGN ) |
1989 - 2021 (33 years)

Pretax Income (Earnings) Margin is 
1.23 (1Y -12.0% )

AMGN Stock Price & Pretax Income (Earnings) Margin

Pretax Income (Earnings) Margin for AMGN competitors.
ALXN CELG GILD BIIB GSK BMY JNJ PFE ABBV
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Pretax Income (Earnings) Margin

chevron_right 2021 0.28 -0.3x
( -1.1% / year avg)
chevron_left 1989 0.41
vertical_align_top Peak 2.4 +6.6x *
vertical_align_bottom Bottom -0.43
arrow_drop_up # Up Years 13 13 of 33
years up.
arrow_drop_down # Down Years 20
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • AMGN's stock price has rallied +113,400% from $0.22 in 1989 , or -3776.7x faster than it's pretax income (earnings) margin over the same period.
  • If AMGN shrinks it's stock at the same rate as it's pretax income (earnings) margin (-1.1%/year) , it's stock price will shrink +89.5% and hit $220.91 over the next 10 years.
  • AMGN's stock price has gone up 0 of the 13 years (0%) it's pretax income (earnings) margin were also up.
* A modified method (see: here) is used to calculate changes that involve negative numbers.
  • AMGN Historical Pretax Income (Earnings) Margin Table

    * A modified method (see: here) is used to calculate changes that involve negative numbers.
    Year Pretax Income (Earnings) Margin YoY % Change* Stock Price YoY % Change (Stock Price)
    4/1/2021 0.28 -78.5% - -
    4/1/2020 1.32 -17.6% - -
    4/1/2019 1.6 -2.7% - -
    4/1/2018 1.64 -2.3% - -
    4/1/2017 1.68 8.0% - -
    4/1/2016 1.56 13.8% - -
    4/1/2015 1.37 27.5% - -
    4/1/2014 1.07 -6.0% - -
    4/1/2013 1.14 -6.3% - -
    4/1/2012 1.22 14.5% - -
    4/1/2011 1.07 -25.9% - -
    4/1/2010 1.44 -0.8% - -
    4/1/2009 1.45 5.4% - -
    4/1/2008 1.38 30.4% - -
    4/1/2007 1.05 -13.0% - -
    4/1/2006 1.21 -21.6% - -
    4/1/2005 1.55 17.6% - -
    4/1/2004 1.31 -16.7% - -
    4/1/2003 1.58 -467.8% - -
    4/1/2002 -0.43 -123.1% - -
    4/1/2001 1.85 16.4% - -
    4/1/2000 1.59 -33.8% - -
    4/1/1999 2.4 32.0% - -
    4/1/1998 1.82 23.2% - -
    4/1/1997 1.48 -15.3% - -
    4/1/1996 1.75 22.7% - -
    4/1/1995 1.42 10.6% - -
    4/1/1994 1.29 -3.9% - -
    4/1/1993 1.34 -1.6% - -
    4/1/1992 1.36 -11986.4% - -
    4/1/1991 -0.01 -104.4% - -
    4/1/1990 0.26 -36.5% - -
    4/1/1989 0.41 - - -

  • About
    Industry: Drug Manufacturers General
    Sector: Healthcare
    Country: US
    IPO Date: 5/1/1987
    Stonk Exchange: NASDAQ
    • Amgen, Inc
    • is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics.
    • The company is headquartered in Thousand Oaks, California and currently employs 21,500 full-time employees.
    • The firm discovers, develops, manufactures and delivers various human therapeutics.
    • The company operates in human therapeutics segment.
    • Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine).
    • The company focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience.
    • Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

  • Pretax Earnings Margin (also known as income before tax ratio) is a financial accounting tool used to measure the operating efficiency of a company. It is a ratio that tells us the percentage of sales that has turned into profits or, in other words, how many cents of profit the business has generated for each dollar of sale before deducting taxes. The pretax profit margin is widely used to compare the profitability of businesses within the same industry.

    For more detailed definitions, please see Investopedia.